Skip to main content
. 2021 Mar 30;7(Suppl 1):S28–S33. doi: 10.1016/j.afos.2021.03.002

Table 2.

Pooled hazard ratios of low lean mass on mortality according to cancer type and measurement index.

Cancer type L3 Skeletal Muscle Index
L3 Psoas Index
n (no. of studies) I2 HR 95% CI n (no. of studies) I2 HR 95% CI
Bile duct (excludes intrahepatic) 100 (1) NA 2.02 [1.12, 3.65] 207 (1) NA 2.92 [1.91, 4.47]
Breast 325 (3) 61% 1.69 [0.79, 3.58] NA
Gastrointestinal 8668 (18) 48% 1.56 [1.36, 1.78] NA
Head and neck 2840 (1) NA 1.92 [1.19, 3.11] NA
Hematopoietic 259 (3) 73% 1.34 [0.51, 3.53] NA
Liver and intrahepatic bile duct 2947 (15) 28% 2.30 [1.89, 2.78] 189 (2) 0% 1.71 [1.03, 2.83]
Lung 546 (4) 49% 2.69 [1.50, 4.85] 161 (1) NA 1.17 [0.66, 2.08]
Ovarian and endometrium 740 (4) 54% 1.18 [0.85, 1.64] 338 (2) 38% 1.25 [0.73, 2.15]
Pancreatic 1109 (5) 0% 1.65 [1.38, 1.97] 1381 (3) 16% 1.62 [1.34, 1.97]
Prostate 226 (1) NA 0.90 [0.54, 1.50] NA
Urinary tract 1529 (10) 48% 1.86 [1.45, 2.38] 254 (2) 0% 2.15 [1.31, 3.51]
Mixed 4293 (5) 61% 1.19 [1.03, 1.38] NA
Overall 23582 (70) 65% 1.66 [1.52, 1.82] 2530 (11) 50% 1.70 [1.38, 2.08]

n, number of subjects; HR, hazard ratio; CI, confidence interval; NA, not applicable.